Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases - PubMed (original) (raw)
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases
M J Pittet et al. J Immunol. 2001.
Abstract
To elucidate the functional heterogeneity of Ag-specific T lymphocyte populations, we combined labeling of lymphocytes with MHC/peptide tetramers and a cell surface affinity matrix for IFN-gamma. Magnetic cell sorting of IFN-gamma-positive lymphocytes allowed the selective enrichment and identification of live Ag-specific cytokine-secreting cells by flow cytometry. Naive, memory, and effector Ag-specific populations were evaluated in healthy HLA-A2 individuals. Significant fractions of influenza- and CMV-specific cells secreted IFN-gamma upon challenge with cognate peptide, consistent with an effector/memory status. The sensitivity of the approach allowed the detection of significant numbers of CMV-specific IFN-gamma-secreting cells ex vivo (i.e., without Ag stimulation). This was not apparent when using previously described assays, namely, ELISPOT or intracellular IFN-gamma staining (cytospot). CD8+ T cells specific for the melamoma-associated Ag Melan-A/MART-1 did not produce IFN-gamma upon challenge with cognate peptide, reminiscent with their naive functional state in healthy individuals. In contrast, CD45RA(low) Melan-A/MART-1 tumor-specific cells from three of three melanoma patients presented levels of activity similar to those found for influenza- or CMV virus-specific lymphocytes, compatible with a functional differentiation into competent effector/memory T lymphocytes in vivo. Notably, a sizable fraction of Melan-A/MART-1-specific cells from a patient secreted IFN-gamma ex vivo following peptide-based vaccination. Thus, the high sensitivity of the assay provides a valuable tool to monitor effector T cell responses in different clinical situations.
Similar articles
- Detection and quantification of CD8(+) T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.
Griffioen M, Borghi M, Schrier PI, Osanto S. Griffioen M, et al. Int J Cancer. 2001 Aug 15;93(4):549-55. doi: 10.1002/ijc.1361. Int J Cancer. 2001. PMID: 11477559 - High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini JC, Romero P. Pittet MJ, et al. J Exp Med. 1999 Sep 6;190(5):705-15. doi: 10.1084/jem.190.5.705. J Exp Med. 1999. PMID: 10477554 Free PMC article. - In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.
Speiser DE, Liénard D, Pittet MJ, Batard P, Rimoldi D, Guillaume P, Cerottini JC, Romero P. Speiser DE, et al. Eur J Immunol. 2002 Mar;32(3):731-41. doi: 10.1002/1521-4141(200203)32:3<731::AID-IMMU731>3.0.CO;2-H. Eur J Immunol. 2002. PMID: 11870617 - Detection and enrichment of antigen-specific CD4+ and CD8+ T cells based on cytokine secretion.
Campbell JD. Campbell JD. Methods. 2003 Oct;31(2):150-9. doi: 10.1016/s1046-2023(03)00125-7. Methods. 2003. PMID: 12957573 Review. - Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.
Pittet MJ, Zippelius A, Valmori D, Speiser DE, Cerottini JC, Romero P. Pittet MJ, et al. Trends Immunol. 2002 Jul;23(7):325-8. doi: 10.1016/s1471-4906(02)02244-5. Trends Immunol. 2002. PMID: 12103339 Review. No abstract available.
Cited by
- Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR).
Provenzano M, Mocellin S, Bonginelli P, Nagorsen D, Kwon SW, Stroncek D. Provenzano M, et al. J Transl Med. 2003 Dec 15;1(1):12. doi: 10.1186/1479-5876-1-12. J Transl Med. 2003. PMID: 14675481 Free PMC article. - Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells.
Frascaroli G, Lecher C, Varani S, Setz C, van der Merwe J, Brune W, Mertens T. Frascaroli G, et al. Front Immunol. 2018 May 25;9:1129. doi: 10.3389/fimmu.2018.01129. eCollection 2018. Front Immunol. 2018. PMID: 29887865 Free PMC article. - Functional heterogeneity of vaccine-induced CD8(+) T cells.
Monsurrò V, Nagorsen D, Wang E, Provenzano M, Dudley ME, Rosenberg SA, Marincola FM. Monsurrò V, et al. J Immunol. 2002 Jun 1;168(11):5933-42. doi: 10.4049/jimmunol.168.11.5933. J Immunol. 2002. PMID: 12023400 Free PMC article. - Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH, Lee KY, Lin SM, Lin HC, Wang CH, Yu CT, Kuo HP. Liu CY, et al. J Cancer Res Clin Oncol. 2010 Jan;136(1):35-45. doi: 10.1007/s00432-009-0634-0. J Cancer Res Clin Oncol. 2010. PMID: 19572148 - Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
Tsuji K, Hamada T, Uenaka A, Wada H, Sato E, Isobe M, Asagoe K, Yamasaki O, Shiku H, Ritter G, Murphy R, Hoffman EW, Old LJ, Nakayama E, Iwatsuki K. Tsuji K, et al. Cancer Immunol Immunother. 2008 Oct;57(10):1429-37. doi: 10.1007/s00262-008-0478-5. Epub 2008 Mar 1. Cancer Immunol Immunother. 2008. PMID: 18311489 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials